 | • レポートコード：MRC2Q12-17884 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、医療用創傷ケア生物製剤のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 医療用創傷ケア生物製剤のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用創傷ケア生物製剤の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 医療用創傷ケア生物製剤のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの医療用創傷ケア生物製剤の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の医療用創傷ケア生物製剤の売上および2028年までの予測に焦点を当てています。 医療用創傷ケア生物製剤のグローバル主要企業には、Smith & Nephew Plc、Stryker Corporation、MIMEDX、Organogenesis, Inc.、Bioventus、Skye Biologics、Anika Therapeutics, Inc.、Alphatec Holdings, Inc.、Kerecis、Integra LifeSciences、Orthocell、3M Company、Convatec Group、Coloplast、Cardinal Health、Mölnlyckeなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 医療用創傷ケア生物製剤市場は、タイプとアプリケーションによって区分されます。世界の医療用創傷ケア生物製剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 生体皮膚代替物、外用剤 【アプリケーション別セグメント】 ホーム、クリニック、病院 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 医療用創傷ケア生物製剤製品概要 - タイプ別市場（生体皮膚代替物、外用剤） - アプリケーション別市場（ホーム、クリニック、病院） - 調査の目的 ・エグゼクティブサマリー - 世界の医療用創傷ケア生物製剤販売量予測2017-2028 - 世界の医療用創傷ケア生物製剤売上予測2017-2028 - 医療用創傷ケア生物製剤の地域別販売量 - 医療用創傷ケア生物製剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別医療用創傷ケア生物製剤販売量 - 主要メーカー別医療用創傷ケア生物製剤売上 - 主要メーカー別医療用創傷ケア生物製剤価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（生体皮膚代替物、外用剤） - 医療用創傷ケア生物製剤のタイプ別販売量 - 医療用創傷ケア生物製剤のタイプ別売上 - 医療用創傷ケア生物製剤のタイプ別価格 ・アプリケーション別市場規模（ホーム、クリニック、病院） - 医療用創傷ケア生物製剤のアプリケーション別販売量 - 医療用創傷ケア生物製剤のアプリケーション別売上 - 医療用創傷ケア生物製剤のアプリケーション別価格 ・北米市場 - 北米の医療用創傷ケア生物製剤市場規模（タイプ別、アプリケーション別） - 主要国別の医療用創傷ケア生物製剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの医療用創傷ケア生物製剤市場規模（タイプ別、アプリケーション別） - 主要国別の医療用創傷ケア生物製剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の医療用創傷ケア生物製剤市場規模（タイプ別、アプリケーション別） - 主要国別の医療用創傷ケア生物製剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の医療用創傷ケア生物製剤市場規模（タイプ別、アプリケーション別） - 主要国別の医療用創傷ケア生物製剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの医療用創傷ケア生物製剤市場規模（タイプ別、アプリケーション別） - 主要国別の医療用創傷ケア生物製剤市場規模（トルコ、サウジアラビア） ・企業情報 Smith & Nephew Plc、Stryker Corporation、MIMEDX、Organogenesis, Inc.、Bioventus、Skye Biologics、Anika Therapeutics, Inc.、Alphatec Holdings, Inc.、Kerecis、Integra LifeSciences、Orthocell、3M Company、Convatec Group、Coloplast、Cardinal Health、Mölnlycke ・産業チェーン及び販売チャネル分析 - 医療用創傷ケア生物製剤の産業チェーン分析 - 医療用創傷ケア生物製剤の原材料 - 医療用創傷ケア生物製剤の生産プロセス - 医療用創傷ケア生物製剤の販売及びマーケティング - 医療用創傷ケア生物製剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 医療用創傷ケア生物製剤の産業動向 - 医療用創傷ケア生物製剤のマーケットドライバー - 医療用創傷ケア生物製剤の課題 - 医療用創傷ケア生物製剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Medical Wound Care Biologics estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Medical Wound Care Biologics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Medical Wound Care Biologics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Medical Wound Care Biologics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Medical Wound Care Biologics include Smith & Nephew Plc, Stryker Corporation, MIMEDX, Organogenesis, Inc., Bioventus, Skye Biologics, Anika Therapeutics, Inc., Alphatec Holdings, Inc. and Kerecis, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Medical Wound Care Biologics companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Medical Wound Care Biologics market. Further, it explains the major drivers and regional dynamics of the global Medical Wound Care Biologics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Smith & Nephew Plc
Stryker Corporation
MIMEDX
Organogenesis, Inc.
Bioventus
Skye Biologics
Anika Therapeutics, Inc.
Alphatec Holdings, Inc.
Kerecis
Integra LifeSciences
Orthocell
3M Company
Convatec Group
Coloplast
Cardinal Health
Mölnlycke
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Medical Wound Care Biologics Segment by Type
Biological Skin Substitutes
Topical Agents
Medical Wound Care Biologics Segment by Application
Home
Clinic
Hospital
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medical Wound Care Biologics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Medical Wound Care Biologics market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Medical Wound Care Biologics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Medical Wound Care Biologics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medical Wound Care Biologics revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Medical Wound Care Biologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Medical Wound Care Biologics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Smith & Nephew Plc, Stryker Corporation, MIMEDX, Organogenesis, Inc., Bioventus, Skye Biologics, Anika Therapeutics, Inc., Alphatec Holdings, Inc. and Kerecis, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Medical Wound Care Biologics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Medical Wound Care Biologics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Wound Care Biologics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Medical Wound Care Biologics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Biological Skin Substitutes
1.2.3 Topical Agents
1.3 Market by Application
1.3.1 Global Medical Wound Care Biologics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Home
1.3.3 Clinic
1.3.4 Hospital
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Medical Wound Care Biologics Market Perspective (2017-2028)
2.2 Medical Wound Care Biologics Growth Trends by Region
2.2.1 Medical Wound Care Biologics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Medical Wound Care Biologics Historic Market Size by Region (2017-2022)
2.2.3 Medical Wound Care Biologics Forecasted Market Size by Region (2023-2028)
2.3 Medical Wound Care Biologics Market Dynamics
2.3.1 Medical Wound Care Biologics Industry Trends
2.3.2 Medical Wound Care Biologics Market Drivers
2.3.3 Medical Wound Care Biologics Market Challenges
2.3.4 Medical Wound Care Biologics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Medical Wound Care Biologics Players by Revenue
3.1.1 Global Top Medical Wound Care Biologics Players by Revenue (2017-2022)
3.1.2 Global Medical Wound Care Biologics Revenue Market Share by Players (2017-2022)
3.2 Global Medical Wound Care Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Medical Wound Care Biologics Revenue
3.4 Global Medical Wound Care Biologics Market Concentration Ratio
3.4.1 Global Medical Wound Care Biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Medical Wound Care Biologics Revenue in 2021
3.5 Medical Wound Care Biologics Key Players Head office and Area Served
3.6 Key Players Medical Wound Care Biologics Product Solution and Service
3.7 Date of Enter into Medical Wound Care Biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Medical Wound Care Biologics Breakdown Data by Type
4.1 Global Medical Wound Care Biologics Historic Market Size by Type (2017-2022)
4.2 Global Medical Wound Care Biologics Forecasted Market Size by Type (2023-2028)
5 Medical Wound Care Biologics Breakdown Data by Application
5.1 Global Medical Wound Care Biologics Historic Market Size by Application (2017-2022)
5.2 Global Medical Wound Care Biologics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Medical Wound Care Biologics Market Size (2017-2028)
6.2 North America Medical Wound Care Biologics Market Size by Type
6.2.1 North America Medical Wound Care Biologics Market Size by Type (2017-2022)
6.2.2 North America Medical Wound Care Biologics Market Size by Type (2023-2028)
6.2.3 North America Medical Wound Care Biologics Market Share by Type (2017-2028)
6.3 North America Medical Wound Care Biologics Market Size by Application
6.3.1 North America Medical Wound Care Biologics Market Size by Application (2017-2022)
6.3.2 North America Medical Wound Care Biologics Market Size by Application (2023-2028)
6.3.3 North America Medical Wound Care Biologics Market Share by Application (2017-2028)
6.4 North America Medical Wound Care Biologics Market Size by Country
6.4.1 North America Medical Wound Care Biologics Market Size by Country (2017-2022)
6.4.2 North America Medical Wound Care Biologics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Medical Wound Care Biologics Market Size (2017-2028)
7.2 Europe Medical Wound Care Biologics Market Size by Type
7.2.1 Europe Medical Wound Care Biologics Market Size by Type (2017-2022)
7.2.2 Europe Medical Wound Care Biologics Market Size by Type (2023-2028)
7.2.3 Europe Medical Wound Care Biologics Market Share by Type (2017-2028)
7.3 Europe Medical Wound Care Biologics Market Size by Application
7.3.1 Europe Medical Wound Care Biologics Market Size by Application (2017-2022)
7.3.2 Europe Medical Wound Care Biologics Market Size by Application (2023-2028)
7.3.3 Europe Medical Wound Care Biologics Market Share by Application (2017-2028)
7.4 Europe Medical Wound Care Biologics Market Size by Country
7.4.1 Europe Medical Wound Care Biologics Market Size by Country (2017-2022)
7.4.2 Europe Medical Wound Care Biologics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Medical Wound Care Biologics Market Size (2017-2028)
8.2 Asia-Pacific Medical Wound Care Biologics Market Size by Type
8.2.1 Asia-Pacific Medical Wound Care Biologics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Medical Wound Care Biologics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Medical Wound Care Biologics Market Share by Type (2017-2028)
8.3 Asia-Pacific Medical Wound Care Biologics Market Size by Application
8.3.1 Asia-Pacific Medical Wound Care Biologics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Medical Wound Care Biologics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Medical Wound Care Biologics Market Share by Application (2017-2028)
8.4 Asia-Pacific Medical Wound Care Biologics Market Size by Region
8.4.1 Asia-Pacific Medical Wound Care Biologics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Medical Wound Care Biologics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Medical Wound Care Biologics Market Size (2017-2028)
9.2 Latin America Medical Wound Care Biologics Market Size by Type
9.2.1 Latin America Medical Wound Care Biologics Market Size by Type (2017-2022)
9.2.2 Latin America Medical Wound Care Biologics Market Size by Type (2023-2028)
9.2.3 Latin America Medical Wound Care Biologics Market Share by Type (2017-2028)
9.3 Latin America Medical Wound Care Biologics Market Size by Application
9.3.1 Latin America Medical Wound Care Biologics Market Size by Application (2017-2022)
9.3.2 Latin America Medical Wound Care Biologics Market Size by Application (2023-2028)
9.3.3 Latin America Medical Wound Care Biologics Market Share by Application (2017-2028)
9.4 Latin America Medical Wound Care Biologics Market Size by Country
9.4.1 Latin America Medical Wound Care Biologics Market Size by Country (2017-2022)
9.4.2 Latin America Medical Wound Care Biologics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Medical Wound Care Biologics Market Size (2017-2028)
10.2 Middle East & Africa Medical Wound Care Biologics Market Size by Type
10.2.1 Middle East & Africa Medical Wound Care Biologics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Medical Wound Care Biologics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Medical Wound Care Biologics Market Share by Type (2017-2028)
10.3 Middle East & Africa Medical Wound Care Biologics Market Size by Application
10.3.1 Middle East & Africa Medical Wound Care Biologics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Medical Wound Care Biologics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Medical Wound Care Biologics Market Share by Application (2017-2028)
10.4 Middle East & Africa Medical Wound Care Biologics Market Size by Country
10.4.1 Middle East & Africa Medical Wound Care Biologics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Medical Wound Care Biologics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Smith & Nephew Plc
11.1.1 Smith & Nephew Plc Company Details
11.1.2 Smith & Nephew Plc Business Overview
11.1.3 Smith & Nephew Plc Medical Wound Care Biologics Introduction
11.1.4 Smith & Nephew Plc Revenue in Medical Wound Care Biologics Business (2017-2022)
11.1.5 Smith & Nephew Plc Recent Developments
11.2 Stryker Corporation
11.2.1 Stryker Corporation Company Details
11.2.2 Stryker Corporation Business Overview
11.2.3 Stryker Corporation Medical Wound Care Biologics Introduction
11.2.4 Stryker Corporation Revenue in Medical Wound Care Biologics Business (2017-2022)
11.2.5 Stryker Corporation Recent Developments
11.3 MIMEDX
11.3.1 MIMEDX Company Details
11.3.2 MIMEDX Business Overview
11.3.3 MIMEDX Medical Wound Care Biologics Introduction
11.3.4 MIMEDX Revenue in Medical Wound Care Biologics Business (2017-2022)
11.3.5 MIMEDX Recent Developments
11.4 Organogenesis, Inc.
11.4.1 Organogenesis, Inc. Company Details
11.4.2 Organogenesis, Inc. Business Overview
11.4.3 Organogenesis, Inc. Medical Wound Care Biologics Introduction
11.4.4 Organogenesis, Inc. Revenue in Medical Wound Care Biologics Business (2017-2022)
11.4.5 Organogenesis, Inc. Recent Developments
11.5 Bioventus
11.5.1 Bioventus Company Details
11.5.2 Bioventus Business Overview
11.5.3 Bioventus Medical Wound Care Biologics Introduction
11.5.4 Bioventus Revenue in Medical Wound Care Biologics Business (2017-2022)
11.5.5 Bioventus Recent Developments
11.6 Skye Biologics
11.6.1 Skye Biologics Company Details
11.6.2 Skye Biologics Business Overview
11.6.3 Skye Biologics Medical Wound Care Biologics Introduction
11.6.4 Skye Biologics Revenue in Medical Wound Care Biologics Business (2017-2022)
11.6.5 Skye Biologics Recent Developments
11.7 Anika Therapeutics, Inc.
11.7.1 Anika Therapeutics, Inc. Company Details
11.7.2 Anika Therapeutics, Inc. Business Overview
11.7.3 Anika Therapeutics, Inc. Medical Wound Care Biologics Introduction
11.7.4 Anika Therapeutics, Inc. Revenue in Medical Wound Care Biologics Business (2017-2022)
11.7.5 Anika Therapeutics, Inc. Recent Developments
11.8 Alphatec Holdings, Inc.
11.8.1 Alphatec Holdings, Inc. Company Details
11.8.2 Alphatec Holdings, Inc. Business Overview
11.8.3 Alphatec Holdings, Inc. Medical Wound Care Biologics Introduction
11.8.4 Alphatec Holdings, Inc. Revenue in Medical Wound Care Biologics Business (2017-2022)
11.8.5 Alphatec Holdings, Inc. Recent Developments
11.9 Kerecis
11.9.1 Kerecis Company Details
11.9.2 Kerecis Business Overview
11.9.3 Kerecis Medical Wound Care Biologics Introduction
11.9.4 Kerecis Revenue in Medical Wound Care Biologics Business (2017-2022)
11.9.5 Kerecis Recent Developments
11.10 Integra LifeSciences
11.10.1 Integra LifeSciences Company Details
11.10.2 Integra LifeSciences Business Overview
11.10.3 Integra LifeSciences Medical Wound Care Biologics Introduction
11.10.4 Integra LifeSciences Revenue in Medical Wound Care Biologics Business (2017-2022)
11.10.5 Integra LifeSciences Recent Developments
11.11 Orthocell
11.11.1 Orthocell Company Details
11.11.2 Orthocell Business Overview
11.11.3 Orthocell Medical Wound Care Biologics Introduction
11.11.4 Orthocell Revenue in Medical Wound Care Biologics Business (2017-2022)
11.11.5 Orthocell Recent Developments
11.12 3M Company
11.12.1 3M Company Company Details
11.12.2 3M Company Business Overview
11.12.3 3M Company Medical Wound Care Biologics Introduction
11.12.4 3M Company Revenue in Medical Wound Care Biologics Business (2017-2022)
11.12.5 3M Company Recent Developments
11.13 Convatec Group
11.13.1 Convatec Group Company Details
11.13.2 Convatec Group Business Overview
11.13.3 Convatec Group Medical Wound Care Biologics Introduction
11.13.4 Convatec Group Revenue in Medical Wound Care Biologics Business (2017-2022)
11.13.5 Convatec Group Recent Developments
11.14 Coloplast
11.14.1 Coloplast Company Details
11.14.2 Coloplast Business Overview
11.14.3 Coloplast Medical Wound Care Biologics Introduction
11.14.4 Coloplast Revenue in Medical Wound Care Biologics Business (2017-2022)
11.14.5 Coloplast Recent Developments
11.15 Cardinal Health
11.15.1 Cardinal Health Company Details
11.15.2 Cardinal Health Business Overview
11.15.3 Cardinal Health Medical Wound Care Biologics Introduction
11.15.4 Cardinal Health Revenue in Medical Wound Care Biologics Business (2017-2022)
11.15.5 Cardinal Health Recent Developments
11.16 Mölnlycke
11.16.1 Mölnlycke Company Details
11.16.2 Mölnlycke Business Overview
11.16.3 Mölnlycke Medical Wound Care Biologics Introduction
11.16.4 Mölnlycke Revenue in Medical Wound Care Biologics Business (2017-2022)
11.16.5 Mölnlycke Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer